We report a rare case of acute neurological Behçet’s disease (neuro-BD) diagnosed concurrently with systemic Behçet’s disease ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...
Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...
Early results from the ongoing QUILT-106 clinical trial (NCT06334991) show that the treatment combination of CD19 chimeric antigen receptor natural killer (CAR-NK) cells with rituximab (Rituxan) can ...
Every time our body encounters a new disease-causing agent, a crucial defence system called adaptive immunity comes into play. T cells, the top agents ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results